.view-toggle-wrapper { display: none; } #content-overview { display: block !important; } #content-technical { display: block !important; margin-top: 50px; border-top: 2px solid #ccc; padding-top: 30px; }

Use the toggle to switch between the simple Overview and the Technical Data content.

Alpha-Lipoic Acid: Benefits, Uses, and Sources

Overview

Plain-English information for everyday use

1. What Is Alpha-Lipoic Acid?

Key Takeaway

Alpha-lipoic acid is an antioxidant your body makes itself; it works in both water and fat and helps turn food into energy and refresh other antioxidants.

Alpha-lipoic acid (also called ALA or thioctic acid) is a sulfur-containing compound that your body makes on its own, inside the energy factories of your cells called mitochondria. There it acts as a helper molecule for the enzymes that turn the food you eat into usable energy. PubChem (National Library of Medicine). PubChem CID 864. Open Source ↗Mayr JA. PMID:24777537. Open Source ↗

It is best known as an antioxidant. What makes it unusual is that it dissolves in both water and fat, so it can work throughout the cell rather than in just one area. It also helps refresh some of the body's other antioxidants, such as vitamins C and E and glutathione, so they can keep doing their normal job. Shay KP. PMID:19664690. Open Source ↗Packer L. PMID:7649494. Open Source ↗

Because the body produces its own supply, alpha-lipoic acid is not a vitamin and is not something you must get from food. It is also sold as a supplement, usually in one of two forms: a standard 50/50 blend (often just labeled "alpha-lipoic acid") and an "R" form (R-ALA) that matches the version the body makes. PubChem (National Library of Medicine). PubChem CID 864. Open Source ↗Shay KP. PMID:19664690. Open Source ↗

2. Signs Your Alpha-Lipoic Acid May Be Running Low

Key Takeaway

Because your body makes its own, there is no recognized dietary deficiency and no blood test for “low” alpha-lipoic acid — so there are no signs to watch for in the usual sense.

This is one place where alpha-lipoic acid is different from a vitamin. Because your body makes its own, there is no recognized dietary deficiency the way there is for, say, vitamin C, and there is no routine blood test for a "low alpha-lipoic acid" level. Mayr JA. PMID:24777537. Open Source ↗

Researchers have noted that the body's own production can be lower in some situations, such as with aging or certain metabolic conditions, but this is a topic of study rather than a defined deficiency with a checklist of symptoms. In short: there is no need to watch for signs of being "low" in the usual sense. Shay KP. PMID:19664690. Open Source ↗

If you are wondering whether a supplement makes sense for you, that is a question for your healthcare provider, not something a symptom list can answer.

3. Who Should Be Careful or Check With a Provider

Key Takeaway

Generally well tolerated, but people on blood sugar or thyroid medicine, those pregnant or breastfeeding, anyone facing surgery, and those on chemotherapy should check with a provider first.

At common supplement amounts, alpha-lipoic acid is generally well tolerated. Even so, several groups have good reasons to talk with a clinician before using it: LiverTox (NIDDK). https://www.ncbi.nlm.nih.gov/books/NBK591554/. Open Source ↗

Anyone taking blood-sugar medicine (such as sulfonylureas or other prescription glucose medications) — alpha-lipoic acid can affect blood sugar levels, so the combination needs monitoring.
Anyone with a thyroid condition or taking thyroid medicine such as levothyroxine — spacing and timing are worth confirming with a pharmacist or doctor.
Anyone scheduled for surgery — it is commonly stopped about two weeks beforehand because of its effect on blood sugar.
Anyone who is pregnant or breastfeeding — there is not enough safety information, so it is best avoided unless a provider specifically advises otherwise.
Anyone receiving chemotherapy — check with your oncologist first, because antioxidants can interact with some chemotherapy.
People with heavy alcohol use or a history of weight-loss (bariatric) surgery — a provider may want to check vitamin B1 (thiamine) first.

There is also a rare autoimmune reaction in which the body makes antibodies that cause low blood sugar. It is uncommon and tends to occur in people with a particular genetic background; both Health Canada and Europe's food-safety authority have noted it on product information. Health Canada. Health Canada Summary Safety Review (alpha-lipoic acid). Open Source ↗EFSA Panel on Food Additives and Flavourings. DOI:10.2903/j.efsa.2021.6577. Open Source ↗

4. How to Get the Best Results

Key Takeaway

Take it about 30 minutes before a meal, keep it away from heat and light, and take it regularly since the body clears it quickly.

Alpha-lipoic acid is absorbed better on a fairly empty stomach, so it is usually taken about 30 minutes before a meal. Food can lower how much gets in. Shay KP. PMID:19664690. Open Source ↗

Take it shortly before eating rather than with a large meal.
Because the body clears it quickly and does not store it, it is taken regularly rather than saved up.
Keep capsules away from heat and light, which the compound is sensitive to.
The "R" form is sometimes chosen for slightly better absorption, while the standard 50/50 form is the one used in most research and is usually less expensive. PubChem (National Library of Medicine). PubChem CID 864. Open Source ↗Shay KP. PMID:19664690. Open Source ↗

As with any supplement, steady, sensible habits and an overall balanced diet matter more than any single timing trick.

5. Side Effects to Know About

Key Takeaway

Usually gentle — mild stomach upset is most common; rare autoimmune low blood sugar and gram-level overdose are the serious things to know.

For most healthy people at common doses, alpha-lipoic acid is well tolerated. The most frequent complaints are mild and stomach-related — some nausea, heartburn, or an upset stomach — along with the occasional headache, skin rash, or a faint sulfur-like smell to the urine. Taking it with a little food often eases the stomach effects. LiverTox (NIDDK). https://www.ncbi.nlm.nih.gov/books/NBK591554/. Open Source ↗

Two less common but more serious points are worth knowing. The first is the rare autoimmune low-blood-sugar reaction mentioned earlier, which usually settles after stopping the supplement. The second is that very large amounts are genuinely dangerous, so supplements should be kept well away from children. Moffa S. PMID:30086435. Open Source ↗Zempleni J. PMID:9278559. Open Source ↗

If anything feels unusual or does not settle — especially repeated shakiness, sweating, or confusion, which can signal low blood sugar — stop and contact your healthcare provider.

6. What the Research Suggests

Key Takeaway

Best studied for nerve comfort — where clinic infusions did better than everyday capsules; a four-year oral trial missed its main goal and it was dropped from a 2023 guideline.

The most-studied area for alpha-lipoic acid is nerve comfort — the population most frequently enrolled in alpha-lipoic acid clinical research. Short courses given by infusion in a clinic setting performed well in pooled studies — important note: intravenous administration is a pharmaceutical drug intervention used in clinical medicine, which is entirely distinct from the oral dietary supplement discussed on this page. Results from everyday oral capsules have been more modest, and a large four-year oral trial did not meet its main goal. In 2023 a major professional guideline stopped including it. Ziegler D. PMID:14984445. Open Source ↗Ziegler D. PMID:21775755. Open Source ↗Mijnhout GS. PMC3272801. Open Source ↗

Other areas — normal glucose metabolism support, modest changes in body weight, and certain hormone-related conditions — have shown mixed and generally small effects in studies. Research on memory and thinking has not shown a clear benefit. Namazi N. PMID:28629898. Open Source ↗Abu-Zaid A. PMID:38044616. Open Source ↗

It helps to read all of this the right way. This research describes biology and study findings; it is not a promise that a supplement changes any health outcome. The honest takeaway is that alpha-lipoic acid supports normal antioxidant and energy processes, and the strongest, simplest story is that of its ordinary role rather than any single dramatic result. Shay KP. PMID:19664690. Open Source ↗Packer L. PMID:7649494. Open Source ↗

7. Top Food Sources

Key Takeaway

Found in tiny, protein-bound amounts in organ meats and some vegetables — food is not a practical way to reach supplement-level doses.

Alpha-lipoic acid appears in small amounts in a range of foods — red meat and organ meats such as liver, heart, and kidney, plus vegetables like spinach, broccoli, and tomatoes. Shay KP. PMID:19664690. Open Source ↗

There is an important caveat, though: the amounts in food are tiny and are bound up inside proteins, so food is not a practical way to reach the amounts used in supplements. A varied diet is good for many reasons, but it is not how people get supplement-level alpha-lipoic acid. Shay KP. PMID:19664690. Open Source ↗

8. What Body Systems Does Alpha-Lipoic Acid Support?

Key Takeaway

It supports normal cellular energy and antioxidant defenses, with the nervous system and metabolism most studied — these describe normal function, not a health claim.

Because it works inside the cell's energy factories and as an antioxidant, alpha-lipoic acid is linked to a few normal, everyday processes: PubChem (National Library of Medicine). PubChem CID 864. Open Source ↗

Cellular energy — it is a helper molecule for enzymes that turn food into energy.
Antioxidant defenses — it helps neutralize unstable molecules and refreshes other antioxidants such as vitamins C and E and glutathione.
Nervous system and metabolism — these are the areas researchers have looked at most closely. Shay KP. PMID:19664690. Open Source ↗Packer L. PMID:7649494. Open Source ↗

These describe the compound's normal role in the body. They are not claims that a supplement changes any health outcome.

9. Frequently Asked Questions

Key Takeaway

Common questions answered: daily use is generally fine for healthy adults, there is no reliable “you’ll feel it by” timeline, R-ALA differs modestly from the standard blend, and some combinations need spacing.

Is it safe to take alpha-lipoic acid every day?

For most healthy adults, common daily amounts are generally well tolerated, with mild stomach upset being the usual complaint. People on blood sugar or thyroid medicine, those who are pregnant or breastfeeding, and anyone heading into surgery should check with a provider first. LiverTox (NIDDK). https://www.ncbi.nlm.nih.gov/books/NBK591554/. Open Source ↗Health Canada. Health Canada Summary Safety Review (alpha-lipoic acid). Open Source ↗

How long until I notice anything?

There is no reliable "you'll feel it by" timeline for general use. In studies of nerve comfort, changes were measured over weeks, and everyday oral results were modest. The body clears it quickly, so it is taken regularly rather than stored. Ziegler D. PMID:14984445. Open Source ↗Ziegler D. PMID:21775755. Open Source ↗

What is the difference between R-ALA and regular alpha-lipoic acid?

Standard supplements are a 50/50 blend of two mirror-image forms. The "R" form matches the version your body makes and is absorbed somewhat better, but it is less shelf-stable and usually costs more. The standard blend is the one used in most research. PubChem (National Library of Medicine). PubChem CID 864. Open Source ↗Shay KP. PMID:19664690. Open Source ↗

Can I take it with my other supplements or medicines?

Some combinations need care. It can add to the blood-sugar-lowering effect of blood sugar medicines, may affect thyroid medicine, and can bind minerals like iron, zinc, and copper if taken at the same time — so those are best spaced apart. Check with a pharmacist about your specific list. Health Canada. Health Canada Summary Safety Review (alpha-lipoic acid). Open Source ↗Zempleni J. PMID:9278559. Open Source ↗

Can I just get it from food?

Not at supplement-level amounts. Foods like organ meats, spinach, and broccoli contain only small amounts, bound inside proteins, so food is not a practical source for the doses used in research. Shay KP. PMID:19664690. Open Source ↗

10. How to Choose a Quality Supplement — Bonus

Key Takeaway

Check the label for the form (standard blend vs R-ALA), favor third-party-tested GMP products, and remember all alpha-lipoic acid is lab-made.

A few simple things separate a well-made product from a vague one:

Look for the form on the label — whether it is the standard blend or the "R" form — rather than a product that leaves it unstated.
Favor brands that publish third-party testing or a Certificate of Analysis and that make products in GMP-certified facilities.
Remember that all alpha-lipoic acid is made in a lab; "natural" on the label refers to the form, not to a plant extract.
If you choose an "R" form, note it is less shelf-stable, so freshness and proper storage matter more. PubChem (National Library of Medicine). PubChem CID 864. Open Source ↗

11. Your Genes & Alpha-Lipoic Acid — Bonus

Key Takeaway

A gene called LIAS helps your body make its own; separately, certain immune-system gene types raise the rare risk of autoimmune low blood sugar, mostly in people of East Asian background.

Genes enter the picture in two small ways. First, a gene called LIAS is part of how your body builds its own alpha-lipoic acid. Mayr JA. PMID:24777537. Open Source ↗

Second, the rare autoimmune low-blood-sugar reaction linked to alpha-lipoic acid is more likely in people who carry certain immune-system gene types (HLA-DRB1*04:06 and *04:03), which are more common in people of Japanese and Korean background, and to a lesser degree in some people of European descent. This is uncommon, and routine genetic testing before taking alpha-lipoic acid is not standard. Moffa S. PMID:30086435. Open Source ↗

12. Traditional Roots — Bonus

Key Takeaway

Alpha-lipoic acid has no traditional or folk-medicine history — it is a modern, laboratory-era discovery.

Unlike many botanicals, alpha-lipoic acid has no traditional or folk-medicine history. It was not used by healers of the past, because it was not discovered until the middle of the twentieth century. Shay KP. PMID:19664690. Open Source ↗

The foods that happen to contain it — organ meats, spinach, and the like — have their own long culinary traditions, but alpha-lipoic acid as a remedy is entirely a modern, laboratory-era story. Shay KP. PMID:19664690. Open Source ↗

13. The Story Behind the Science — Bonus

Key Takeaway

Discovered in the 1930s-40s and isolated in 1951, it has been used as a prescription drug in Europe and Japan and studied widely with mixed results.

Alpha-lipoic acid was first noticed in the 1930s and 1940s as a growth factor that certain bacteria needed, and it was isolated in pure form in 1951. For decades afterward it was used as a prescription medicine in parts of Europe and Japan, where it is known as thioctic acid. Shay KP. PMID:19664690. Open Source ↗

Since then it has been studied for a wide range of uses with mixed results — a reminder that a long history of research is not the same as proof that a supplement changes a health outcome. The clearest thread remains its ordinary role in energy metabolism and antioxidant defense. Shay KP. PMID:19664690. Open Source ↗Packer L. PMID:7649494. Open Source ↗

14. Blood Tests That May Show Changes — Bonus

Key Takeaway

Alpha-lipoic acid is not routinely measured, but the rare autoimmune reaction can skew insulin tests and co-formulated biotin can skew some lab assays — tell your provider and lab.

Alpha-lipoic acid itself is not something doctors routinely measure in blood. But it is worth knowing two ways it can affect lab results.

The rare autoimmune reaction tied to alpha-lipoic acid can make insulin readings look unusually high on some tests, which can be confusing during a workup for low blood sugar.
Some alpha-lipoic acid products also contain biotin (vitamin B7), and high-dose biotin is well known to skew certain lab immunoassays — the US FDA has warned about this. Moffa S. PMID:30086435. Open Source ↗U.S. Food and Drug Administration. FDA Safety Communication (biotin). Open Source ↗

The simple step is to tell your provider and the lab about every supplement you take, including alpha-lipoic acid and anything containing biotin, so results can be read correctly. U.S. Food and Drug Administration. FDA Safety Communication (biotin). Open Source ↗

✓ Last Reviewed: June 2026

Alpha-Lipoic Acid

Technical Data

Clinical decision-support reference for healthcare professionals

CLINICAL SUMMARY

Alpha-Lipoic Acid (thioctic acid; (R/S)-1,2-dithiolane-3-pentanoic acid)

Endogenously synthesized organosulfur antioxidant; physiologically a mitochondrial 2-oxoacid dehydrogenase cofactor, and — as the supplemental free acid — a network antioxidant, transition-metal chelator, and Nrf2 inducer.

Overall Evidence

LIMITED

Primary Uses Studied

MODERATEHealthy nerve function & comfort (short-term clinic studies) · Pooled RCTs of 600 mg/day given in clinic by infusion over ~3 weeks show short-term symptom benefit.
LIMITEDHealthy nerve function (long-term oral use) · 4-year oral RCT (NATHAN 1) missed its primary composite endpoint (p=0.105).
LIMITEDGlycemic / anthropometric markers · Meta-analyses show small, inconsistent effects on fasting glycemic markers and weight.
INSUFFICIENTMemory and thinking · No demonstrated benefit in controlled evaluation.

Standard Dose Range

Dietary: No dietary requirement or RDA; endogenously synthesized in mitochondria.
Functional: Common OTC supplement range ~300-600 mg/day oral; absorption favored ~30 min pre-meal.
High-Dose (studied): Trial regimens: 600 mg/day given in clinic by infusion over 3 weeks (nerve-comfort studies); oral 600-1800 mg/day in RCTs. Acute ingestion >6 g is potentially lethal.

Key Safety Flags

🟢 STANDARD Generally well tolerated at common oral doses; mild dose-related GI effects most frequent.
🟠 CAUTION Additive hypoglycemia with blood-sugar-lowering therapy; a rare autoimmune blood-sugar reaction (sulfhydryl trigger; HLA-DRB1*04:06 / *04:03). Acute overdose risk at gram-level doses.

Pregnancy / Lactation

Insufficient human safety data; avoid unless clinician-directed. (⚪ not graded)

Drug Interaction Burden

Moderate: additive hypoglycemia with insulin/secretagogues (PD); possible reduced levothyroxine absorption; divalent-cation (Fe/Zn/Cu) chelation if co-ingested. Separate dosing.

Monitoring Quick-Ref

Capillary / fasting glucose: In patients on blood-sugar-lowering therapy; monitor for hypoglycemia, especially at initiation.
Thyroid function (if on levothyroxine): Confirm dose separation; reassess TSH if timing changes.
Clinical hypoglycemia surveillance: Counsel on autonomic symptoms; consider IAS if recurrent fasting hypoglycemia with high insulin.

⚠️ Lab Interference

ALPHA-LIPOIC ACID DOES NOT DIRECTLY INTERFERE WITH ROUTINE CLINICAL CHEMISTRY OR IMMUNOASSAYS. The clinically relevant signals are indirect. (1) In the rare autoimmune blood-sugar reaction associated with sulfhydryl exposure, anti-insulin antibodies produce markedly elevated total insulin immunoassay values with hypoglycemia, which can confound an endogenous-hyperinsulinism workup. (2) Many alpha-lipoic acid products are co-formulated with biotin; high-dose biotin distorts streptavidin-biotin immunoassays (e.g., thyroid panels, troponin) per the FDA safety communication. Action: confirm exact supplement content, and apply assay-appropriate biotin washout (commonly held interpretation: spacing of 8 or more hours for standard biotin doses; longer for very high doses) before interpreting affected assays. Moffa S. PMID:30086435. Open Source ↗U.S. Food and Drug Administration. FDA Safety Communication (biotin). Open Source ↗

Note: nerve-comfort trial data referenced in this summary was generated in specific research populations. This reference summarizes published evidence classifications only and does not constitute a recommendation for any population.

Clinical bottom line: Generally well tolerated at common oral doses with an overall LIMITED evidence base — strongest for short-term clinic-based symptom relief supporting healthy nerve function, weakest for durable, long-term functional changes. Endogenously synthesized (no deficiency state); monitoring during use is safety-driven. No taper required on discontinuation.

1. Chemical Identity & Forms

Key Takeaway

Organosulfur dithiolane (thioctic acid), C8H14O2S2, MW 206.33; the alpha-lipoic acid/DHLA redox couple is the functional unit; R-(+) is endogenous, racemate is the common commercial and clinical form.

Alpha-lipoic acid (thioctic acid) is an organosulfur compound, (R/S)-1,2-dithiolane-3-pentanoic acid, C8H14O2S2, MW 206.33. The chemically defining feature is a strained five-membered dithiolane ring bearing an intramolecular disulfide, reduced in vivo to the dithiol dihydrolipoic acid (DHLA) — the alpha-lipoic acid / DHLA couple is the functional redox unit. PubChem (National Library of Medicine). PubChem CID 864. Open Source ↗

A single stereocenter gives two enantiomers. The R-(+) form (CAS 1200-22-2) is the biologically synthesized species; commercial racemate (CAS 1077-28-7) is a 1:1 R/S mixture. The molecule is amphipathic, partitioning into both aqueous and lipid compartments. PubChem (National Library of Medicine). PubChem CID 864. Open Source ↗Shay KP. PMID:19664690. Open Source ↗

Racemic alpha-lipoic acid — the form used in most clinical trials and most OTC products.
R-alpha-lipoic acid (R-ALA) — matches the endogenous enantiomer; higher Cmax but less stable.
Stabilized sodium/potassium R-lipoate salts — formulated to mitigate the free acid's tendency to polymerize above its melting point (47-49 degrees C). PubChem (National Library of Medicine). PubChem CID 864. Open Source ↗Shay KP. PMID:19664690. Open Source ↗

2. Mechanism of Action

Key Takeaway

Endogenously a mitochondrial 2-oxoacid dehydrogenase cofactor; the supplemental free acid acts at high doses as a network antioxidant, metal chelator, and Nrf2 inducer — not as a dose-responsive cofactor.

Physiologically, lipoic acid is an enzyme-bound cofactor: covalently amidated to a lysine residue (lipoyl-lysine) on the mitochondrial 2-oxoacid dehydrogenase complexes (pyruvate, alpha-ketoglutarate, and branched-chain ketoacid dehydrogenases) and the glycine cleavage system, where it shuttles acyl groups and reducing equivalents. This endogenous pool is synthesized in situ, not derived from the free acid in supplements. Cronan JE. PMID:32508887. Open Source ↗Mayr JA. PMID:24777537. Open Source ↗

Supplemental free alpha-lipoic acid acts through high-dose effects rather than as a cofactor. Its best-characterized actions are redox: direct radical scavenging, and — as DHLA — regeneration of other antioxidants in Packer's 'antioxidant network' (ascorbate, alpha-tocopherol, glutathione, ubiquinol). It also chelates transition metals and induces Nrf2-dependent cytoprotective gene expression. Packer L. PMID:7649494. Open Source ↗Scott BC. PMID:7516789. Open Source ↗

The distinction matters clinically: the cofactor role is not dose-responsive to oral intake, so supplement effects (if any) derive from the high-dose redox and signaling actions of the free acid, which clear rapidly.

3. Pharmacokinetics (ADME)

Key Takeaway

~30% oral bioavailability with extensive first-pass extraction, Tmax 0.5-1 h, t½ ~30 min, ~20% food effect; R-enantiomer Cmax 40-50% higher; >80% renal metabolite excretion; no accumulation.

Oral absorption is rapid but incomplete: absolute bioavailability is approximately 30% owing to extensive first-pass hepatic extraction, with Tmax 0.5-1 h and a short elimination half-life of about 30 minutes. Food reduces Cmax by roughly 20%, supporting dosing ~30 minutes before meals. Teichert J. PMID:14551180. Open Source ↗Shay KP. PMID:19664690. Open Source ↗

Enantioselectivity is measurable: the R-(+) enantiomer reaches a Cmax roughly 40-50% higher than S-(-) after racemate dosing. Metabolism proceeds by beta-oxidation and S-methylation of the side chain to a characterized set of metabolites, with more than 80% of an administered dose recovered in urine as metabolites. There is no meaningful accumulation; the short half-life means a rapidly cleared exposure rather than sustained plasma levels. Schupke H. PMID:11353754. Open Source ↗Teichert J. PMID:14551180. Open Source ↗

4. Organ System Effects

Key Takeaway

Documented effects cluster in nerve, mitochondrial, and antioxidant systems, largely from preclinical and surrogate endpoints — biology, not established outcome benefit.

Documented effects cluster around tissues with high oxidative and bioenergetic load: Shay KP. PMID:19664690. Open Source ↗

Peripheral nervous system — preclinical models report improved nerve blood flow and conduction velocity under elevated blood glucose conditions studied in research settings.
Mitochondrial bioenergetics — aged-animal models report partial restoration of mitochondrial function and reduced oxidative markers.
Antioxidant systems — augmentation of endogenous glutathione-based defenses via the network-recycling mechanism. Cameron NE. PMID:9562342. Open Source ↗Hagen TM. PMID:11854487. Open Source ↗Liu J. PMID:11854529. Open Source ↗

Preclinical and surrogate-endpoint effects describe biology and do not establish clinical outcome benefit; see Section 6 for the graded clinical evidence.

5. Dose Tiers

Key Takeaway

No dietary requirement; functional ~300-600 mg/day oral pre-meal; trial regimens 600 mg/day (clinic infusion) x 3 weeks and oral 600-1800 mg/day; acute ingestion >6 g is potentially lethal.

There is no dietary requirement (endogenous synthesis). Supplemental and trial regimens span three tiers: Shay KP. PMID:19664690. Open Source ↗

Functional/OTC: ~300-600 mg/day oral, taken ~30 minutes pre-meal to limit the food effect.
High-Dose (studied): 600 mg/day given in clinic by infusion for ~3 weeks in nerve comfort clinical trials; oral 600-1800 mg/day in controlled studies.
R-ALA is sometimes selected for kinetic reasons; racemate is the form behind most trial data and is typically less expensive. Ziegler D. PMID:14984445. Open Source ↗Ziegler D. PMID:21775755. Open Source ↗

Acute ingestion above ~6 g is potentially lethal (serious neurological effects, lactic acidosis) with no specific antidote; counsel accordingly and keep away from children.

6. Clinical Evidence

Key Takeaway

Evidence is strongest (MODERATE) for short-term clinic-based symptom relief supporting healthy nerve function and weakest for durable, long-term functional changes (NATHAN 1 missed its primary endpoint); overall grade LIMITED, and a major professional guideline stopped including it in 2023.

The evidence base is heavily weighted toward nerve-comfort outcomes, and it separates cleanly by route and duration (a Three-States reading): Ziegler D. PMID:14984445. Open Source ↗

Short-term clinic infusion (MODERATE): a meta-analysis of 600 mg/day given in clinic by infusion over ~3 weeks reported short-term improvement in nerve-comfort measures.
Oral, long-term (LIMITED / null on the hard endpoint): the 4-year oral NATHAN 1 RCT did not meet its primary composite endpoint (p=0.105), though some secondary impairment measures moved.
Supportive oral RCTs and pooled analyses (MIXED): symptom-scale benefits in some trials of modest size. Ziegler D. PMID:14984445. Open Source ↗Ziegler D. PMID:21775755. Open Source ↗Mijnhout GS. PMC3272801. Open Source ↗Didangelos T. PMC7690794. Open Source ↗

Outside nerve function, meta-analyses of fasting glycemic and body-composition measures and certain hormone-related conditions show small and inconsistent effects. Memory and thinking evidence is INSUFFICIENT. Reflecting this, alpha-lipoic acid was removed from a major professional care guideline in 2023. Namazi N. PMID:28629898. Open Source ↗Abu-Zaid A. PMID:38044616. Open Source ↗

These are evidence-quality statements, not efficacy claims. The overall grade is LIMITED, strongest for short-term clinic-based symptom relief and weakest for durable, long-term functional changes.

7. Pharmacogenomics & Genetics

Key Takeaway

Endogenous synthesis depends on LIAS/LIPT genes; supplement-relevant susceptibility to a rare autoimmune blood-sugar reaction tracks HLA-DRB1*04:06/*04:03; routine HLA typing is not standard.

Two genetic threads are relevant. First, the endogenous cofactor pool depends on the lipoic acid synthesis pathway (LIAS, LIPT1/2); rare biallelic LIAS variants cause a severe inborn mitochondrial condition unrelated to supplement use. Mayr JA. PMID:24777537. Open Source ↗Cronan JE. PMID:32508887. Open Source ↗

Second, and more clinically actionable for supplement users, susceptibility to the alpha-lipoic acid-associated autoimmune blood-sugar reaction tracks strongly with HLA class II alleles: HLA-DRB1*04:06 carries a very high odds ratio in Japanese and Korean populations, with HLA-DRB1*04:03 implicated at lower effect size in some European-ancestry cases. Routine pre-treatment HLA typing is not routinely recommended. Moffa S. PMID:30086435. Open Source ↗

8. Adverse Effects

Key Takeaway

Good tolerability at common oral doses; common dose-related GI effects, a rare autoimmune blood-sugar reaction (usually remitting after cessation), and dangerous gram-level overdose.

Tolerability at common oral doses is good; adverse effects are largely dose-related and reversible. LiverTox (NIDDK). https://www.ncbi.nlm.nih.gov/books/NBK591554/. Open Source ↗

Common: dose-dependent GI effects (nausea, dyspepsia, abdominal discomfort), headache, pruritus/rash, and a sulfurous urine odor.
Rare but serious: a rare autoimmune blood-sugar reaction (hyperinsulinemic hypoglycemia from anti-insulin antibodies), typically remitting weeks to months after discontinuation in 60-80% of cases.
Overdose: gram-level acute ingestion (>6 g) can cause serious neurological effects and lactic acidosis and has been fatal; management is supportive. Moffa S. PMID:30086435. Open Source ↗Zempleni J. PMID:9278559. Open Source ↗

9. Drug Interactions

Key Takeaway

Moderate, predictable interactions: additive hypoglycemia with blood-sugar-lowering medicines, possible reduced levothyroxine absorption, and divalent-cation chelation — space dosing.

The interaction profile is moderate and predictable: Health Canada. Health Canada Summary Safety Review (alpha-lipoic acid). Open Source ↗

Blood-sugar-lowering agents (insulin, sulfonylureas, and other secretagogues) — pharmacodynamic additive hypoglycemia; monitor glucose and counsel on symptoms.
Levothyroxine — possible reduced absorption; separate administration times.
Divalent/transition-metal cations (iron, zinc, copper) — chelation can reduce mineral absorption when co-ingested; space dosing.
Cytotoxic chemotherapy — theoretical antioxidant interference; defer to the treating oncologist. Health Canada. Health Canada Summary Safety Review (alpha-lipoic acid). Open Source ↗Zempleni J. PMID:9278559. Open Source ↗

10. Cautions and Considerations

Key Takeaway

No absolute reason to avoid at common doses for healthy adults; the population red flags, depletion, lab-interference, and monitoring panels follow.

There is no absolute reason to avoid at common doses for healthy adults, but several populations warrant caution or avoidance. Regulatory bodies (EFSA; Health Canada) have specifically flagged the rare autoimmune blood-sugar reaction / hypoglycemia signal on product information. EFSA Panel on Food Additives and Flavourings. DOI:10.2903/j.efsa.2021.6577. Open Source ↗Health Canada. Health Canada Summary Safety Review (alpha-lipoic acid). Open Source ↗

10a. Patient Population Red Flags

🟡 Renal impairment — Metabolites are renally cleared; data limited — use cautiously.
🟡 Hepatic impairment — Hepatic metabolism; rare hepatotoxicity signals reported.
⚪ Pregnancy — Insufficient safety data — avoid unless clinician-directed.
⚪ Lactation — Insufficient safety data — avoid unless clinician-directed.
🔴 Pediatric — Gram-level overdose potentially lethal; only specialist-supervised. Keep away from children.
🟢 Geriatric — Generally tolerated; attend to polypharmacy and hypoglycemia risk.
🟠 Polypharmacy (blood-sugar-lowering medicines) — Additive hypoglycemia — monitor glucose, especially at initiation.
🟠 Peri-operative — Commonly discontinued ~2 weeks pre-operatively due to glycemic effect.
🟢 Athletes (WADA) — Not listed on the WADA Prohibited List. Moffa S. PMID:30086435. Open Source ↗Health Canada. Health Canada Summary Safety Review (alpha-lipoic acid). Open Source ↗LiverTox (NIDDK). https://www.ncbi.nlm.nih.gov/books/NBK591554/. Open Source ↗

10b. Drug-Nutrient Depletion Table

Alpha-lipoic acid is a supplement rather than a depleting xenobiotic, so the classic drug-induced nutrient-depletion framework does not meaningfully apply — there is no established depletion across the standard drug-nutrient classes. The documented nutrient-level interactions are interactional, not depletional: Zempleni J. PMID:9278559. Open Source ↗

Nutrient	Direction / mechanism	Action
Iron, zinc, copper	Reduced absorption via cation chelation when co-ingested	Separate dosing by 2+ hours
Biotin (vitamin B7)	Shared SMVT transport — theoretical competition at high co-intake	Note co-formulated biotin; clinical depletion not established

Zempleni J. PMID:9278559. Open Source ↗

10c. Lab Interference Panel

Alpha-lipoic acid does not directly interfere with routine assays. Two indirect signals require awareness across the standard panels: Moffa S. PMID:30086435. Open Source ↗

Panel	Interference	Note
Glycemic / insulin	Indirect (IAS)	Anti-insulin antibodies elevate total insulin immunoassay during hypoglycemia workup
Thyroid / cardiac (immunoassay)	Indirect (co-formulated biotin)	High-dose biotin distorts streptavidin-biotin assays per FDA; apply washout
Reproductive hormones	None documented	—
Stress / adrenal	None documented	—
Vitamin panel	None documented	—
Oncology markers	None documented	—
Inflammatory markers	None documented	—
Hepatic / renal chemistry	None documented	—

Moffa S. PMID:30086435. Open Source ↗U.S. Food and Drug Administration. FDA Safety Communication (biotin). Open Source ↗

10d. Monitoring Protocol Template

Baseline: medication review (blood-sugar-lowering medicines, levothyroxine), glucose status, supplement-content verification (biotin co-formulation).
4-6 weeks: hypoglycemia surveillance in patients on glucose-lowering therapy; tolerability check.
12 weeks: reassess rationale and any symptom-scale target; confirm continued indication.
Annual: routine review; re-verify product and interactions.
Red flags: recurrent fasting hypoglycemia with inappropriately high insulin (consider IAS); new rash or GI intolerance. Health Canada. Health Canada Summary Safety Review (alpha-lipoic acid). Open Source ↗Moffa S. PMID:30086435. Open Source ↗

Discontinuation: no taper is required — the short half-life and absence of physical dependence permit abrupt cessation. Stop promptly if IAS is suspected, and discontinue ~2 weeks before elective surgery.

11. Combinations & Synergy

Key Takeaway

Mechanistic antioxidant-network synergy is plausible but not demonstrated as additive clinical benefit; flag biotin co-formulation and separate mineral dosing.

Mechanistic synergy is plausible within the antioxidant network — alpha-lipoic acid regenerates ascorbate, alpha-tocopherol, glutathione, and ubiquinol — and such combinations are common in formulations. This is a mechanistic rationale, not demonstrated additive clinical benefit. Packer L. PMID:7649494. Open Source ↗Shay KP. PMID:19664690. Open Source ↗

With blood-sugar-lowering regimens: monitor for an additive effect on blood sugar rather than assume benefit.
With biotin-containing stacks: flag the assay-interference implication (Section 10c).
With mineral supplements: separate dosing to avoid chelation losses. Shay KP. PMID:19664690. Open Source ↗

12. Lab Monitoring + Repletion

Key Takeaway

No validated status biomarker and no deficiency to replete — monitoring during use is safety-driven (glucose, thyroid), not status-driven.

There is no validated status biomarker for alpha-lipoic acid and no deficiency state to replete — it is endogenously synthesized and not a measured nutritional parameter. Plasma levels are not monitored clinically given the short half-life and rapid clearance. Shay KP. PMID:19664690. Open Source ↗Teichert J. PMID:14551180. Open Source ↗

Monitoring during use is therefore safety-driven (glucose in patients on blood-sugar-lowering therapy; thyroid status if on levothyroxine), not status-driven. This is distinct from Section 10c, which addresses assays corrupted by use rather than tests of the substance itself.

13. Traditional Medicine

Key Takeaway

No traditional or ethnobotanical history — a modern compound isolated in 1951, later a prescription drug in parts of Europe and Japan.

Alpha-lipoic acid has no traditional or ethnobotanical medicinal history. It is a modern, laboratory-era compound — identified as a microbial growth factor in the 1930s-40s and isolated in 1951 — with no pre-scientific use to report. Its later regulatory status as a prescription drug in parts of Europe and Japan is a modern pharmaceutical development, not a traditional one. Shay KP. PMID:19664690. Open Source ↗

14. Quality Control

Key Takeaway

All material is synthetic (no botanical route); specify enantiomeric form, prefer CoA / third-party-tested cGMP product, and note R-ALA's lower stability.

All commercial alpha-lipoic acid is synthetic; there is no botanical extraction route at scale. Racemate is produced by sulfuration of an octanoic-acid-derived precursor; R-ALA is obtained by chiral resolution. The free acid melts at 47-49 degrees C and polymerizes when melted, which is why stabilized sodium/potassium R-lipoate salts are used in some products. PubChem (National Library of Medicine). PubChem CID 864. Open Source ↗Shay KP. PMID:19664690. Open Source ↗

Specify enantiomeric form on the label (racemate vs R-ALA); R-ALA is less shelf-stable.
Prefer products with Certificate of Analysis, third-party identity/purity testing, and cGMP manufacture.
'Natural' labeling refers to the enantiomer, not a plant origin — all material is synthesized. PubChem (National Library of Medicine). PubChem CID 864. Open Source ↗

✓ Last Reviewed: June 2026

Clinical decisions remain the responsibility of the prescribing clinician.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.